4//SEC Filing
Rolfe Mark 4
Accession 0001441848-10-000023
CIK 0001441848other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 2:07 PM ET
Size
8.1 KB
Accession
0001441848-10-000023
Insider Transaction Report
Form 4
Rolfe Mark
Sr. Vice Pres. and CSO
Transactions
- Disposition to Issuer
Comon Stock
2010-04-21$27.00/sh−21,333$575,991→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2010-04-21$27.00/sh−64,000$1,728,000→ 0 totalExercise: $10.86Exp: 2016-08-20→ Common Stock (64,000 underlying)
Footnotes (2)
- [F1]These shares were canceled and exchanged for a cash payment of $575,991.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. Includes shares not previously reported that were acquired under a Section 423 employee stock purchase plan
- [F2]This stock option was canceled and exchanged for a cash payment of $1,032,960.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.
Documents
Issuer
FACET BIOTECH CORP
CIK 0001441848
Entity typeother
Related Parties
1- filerCIK 0001469308
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 2:07 PM ET
- Size
- 8.1 KB